OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 16

Showing 16 citing articles:

DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 9

Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20

Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway
Jiangfang Lian, Hangyuan Guo, Zuoquan Zhong, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access

Edaravone is a Therapeutic Candidate for Doxorubicin‐Induced Cardiomyopathy by Activating the Nrf2 Pathway
Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access

Androgen receptor alleviates doxorubicin-induced endoplasmic reticulum stress and myocardial injury by interacting with SERCA2a
Shuwei Ning, Jianhui Li, Mei He, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Circ-0006332 stimulates cardiomyocyte pyroptosis via the miR-143/TLR2 axis to promote doxorubicin-induced cardiac damage
Ping Zhang, Yuanyuan Liu, Yuliang Zhan, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2

Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model
Michaela Adamcová, Helena Párová, Olga Lenčová-Popelová, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1

Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers
Isabel Moscoso, Moisés Rodríguez‐Mañero, María Cebro-Márquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11910-11910
Open Access | Times Cited: 1

Genetics in the diagnosis and treatment of cardiovascular diseases
Kevin P. Bliden, Sahib Singh, Roni Shanoada, et al.
Journal of Translational Genetics and Genomics (2024) Vol. 8, Iss. 2, pp. 186-206
Open Access

Prospects of using miRNA-378 as a biomarker for cardiovascular diseases: A literature review
Amina M. Alieva, Nyurzhanna Kh. Khadzhieva, Irina E. Baykova, et al.
Cardiosomatics (2024) Vol. 15, Iss. 3, pp. 221-230
Open Access

Neoadjuvant chemotherapy and perioperative cardiotoxicity
Yingzhou Tu, Suli Zhou, Haoran Wang, et al.
Journal of Anesthesia and Translational Medicine (2024)
Open Access

The Role of MicroRNAs in the Pathogenesis of Doxorubicin-Induced Vascular Remodeling
Ekaterina Podyacheva, Julia Snezhkova, Anatoliya Onopchenko, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13335-13335
Open Access

Allelic variant 6A (rs35068180) of the MMP-3 promoter region as a predictor of cardiotoxicity after the end of adjuvant chemotherapy with doxorubicin in patients with breast cancer
I. A. Karput, V. A. Snezhitsky, M. N. Kurbat, et al.
Russian Journal of Cardiology (2023) Vol. 29, Iss. 1, pp. 5579-5579
Open Access | Times Cited: 1

Page 1

Scroll to top